Free Trial
→ The $7 company helping Nvidia build the world’s first trillion-dollar robot … (From Weiss Ratings) (Ad) Buy DOX Stock  Free DOX Stock Alerts

Amdocs (DOX) Financials

Amdocs logo
$91.23 -1.13 (-1.22%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$90.65 -0.58 (-0.64%)
As of 06/20/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Amdocs

Annual Income Statements for Amdocs

This table shows Amdocs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Net Income / (Loss) Attributable to Common Shareholders		 422 446 409 437 354 479 498 688 550 541 493
Consolidated Net Income / (Loss)		 422 446 409 437 354 479 498 688 550 543 496
Net Income / (Loss) Continuing Operations		 422 446 409 437 354 479 498 688 550 543 496
Total Pre-Tax Income 		490 513 485 513 422 568 583 814 648 636 591
Total Operating Income		 496 516 483 517 428 570 595 599 665 654 629
Total Gross Profit		 1,257 1,294 1,310 1,359 1,380 1,433 1,413 1,478 1,619 1,728 1,755
Total Revenue		 3,564 3,644 3,718 3,867 3,975 4,087 4,169 4,289 4,577 4,888 5,005
Operating Revenue		 3,564 3,644 3,718 3,867 3,975 4,087 4,169 4,289 4,577 4,888 5,005
Total Cost of Revenue		 2,307 2,349 2,408 2,508 2,595 2,653 2,756 2,811 2,958 3,160 3,250
Operating Cost of Revenue		 2,307 2,349 2,408 2,508 2,595 2,653 2,756 2,811 2,958 3,160 3,250
Total Operating Expenses		 761 778 827 842 951 864 819 879 954 1,074 1,127
Selling, General & Admin Expense		 445 440 465 473 481 492 459 487 529 571 573
Research & Development Expense		 258 255 252 259 277 274 282 313 355 375 361
Amortization Expense		 58 70 110 110 108 97 78 79 71 57 62
Restructuring Charge		 0.00 13 - - - - - 0.00 0.00 71 131
Total Other Income / (Expense), net		 -6.10 -2.54 1.56 -4.42 -6.77 -1.86 -11 216 -16 -18 -38
Other Income / (Expense), net		 - - - -4.42 - -1.86 -11 216 -16 -18 -38
Income Tax Expense		 67 67 75 76 67 88 85 126 99 93 95
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - - 0.00 0.00 2.25 3.12
Basic Earnings per Share		 $2.65 $2.89 $2.74 $2.99 $2.49 $3.49 $3.73 $5.36 $4.47 $4.52 $4.27
Weighted Average Basic Shares Outstanding		 156.70M 151.15M 147.13M 144.39M 140.18M 134.77M 131.54M 124.87M 120.84M 117.35M 112.89M
Diluted Earnings per Share		 $2.62 $2.85 $2.71 $2.96 $2.47 $3.47 $3.71 $5.32 $4.44 $4.49 $4.25
Weighted Average Diluted Shares Outstanding		 156.70M 151.15M 147.13M 144.39M 140.18M 134.77M 131.54M 124.87M 120.84M 117.35M 112.89M
Weighted Average Basic & Diluted Shares Outstanding		 156.70M 151.15M 147.13M 144.39M 140.18M 134.77M 131.54M 124.87M 120.84M 117.35M 112.89M
Cash Dividends to Common per Share		 $0.60 $0.67 $0.76 $0.86 $0.97 $1.11 $1.27 $1.41 $1.55 $1.70 $1.87

Quarterly Income Statements for Amdocs

No quarterly income statements for Amdocs are available.

Annual Cash Flow Statements for Amdocs

This table details how cash moves in and out of Amdocs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Net Change in Cash & Equivalents		 89 -68 -267 -119 -231 53 512 -274 -136 -53 -174
Net Cash From Operating Activities		 709 773 620 636 557 656 658 926 757 823 724
Net Cash From Continuing Operating Activities		 709 773 620 636 557 656 658 926 757 823 724
Net Income / (Loss) Continuing Operations		 422 446 409 437 354 479 498 688 550 543 496
Consolidated Net Income / (Loss)		 422 446 409 437 354 479 498 688 550 543 496
Depreciation Expense		 163 175 212 215 211 206 198 209 225 196 193
Amortization Expense		 - - - - 0.00 0.00 0.14 0.55 0.56 0.58 0.60
Non-Cash Adjustments To Reconcile Net Income		 42 39 36 40 49 39 35 -170 65 92 110
Changes in Operating Assets and Liabilities, net		 83 113 -37 -55 -57 -68 -73 198 -82 -9.07 -76
Net Cash From Investing Activities		 -299 -380 -441 -185 -362 -87 -462 -329 -263 -224 -127
Net Cash From Continuing Investing Activities		 -299 -380 -441 -185 -362 -87 -462 -329 -263 -224 -127
Purchase of Property, Plant & Equipment		 -112 -121 -130 -133 -231 -128 -206 -210 -227 -124 -105
Acquisitions		 -181 -263 -283 -18 -355 -61 -249 -143 -24 -122 -87
Purchase of Investments		 -390 -250 -371 -282 -76 0.00 -0.75 -277 -34 0.00 -9.06
Sale of Property, Plant & Equipment		 - - - - - - - 0.00 0.00 0.00 0.00
Divestitures		 - - - - - 0.00 0.00 289 10 0.00 0.00
Sale and/or Maturity of Investments		 379 253 362 278 303 101 0.00 18 22 26 69
Other Investing Activities, net		 3.87 1.41 -19 -30 -3.16 0.62 -6.10 -6.08 -8.53 -4.30 5.32
Net Cash From Financing Activities		 -322 -461 -446 -570 -426 -517 315 -871 -630 -651 -771
Net Cash From Continuing Financing Activities		 -322 -461 -446 -570 -426 -517 315 -871 -630 -651 -771
Repurchase of Common Equity		 -372 -454 -413 -341 -419 -398 -361 -680 -508 -490 -563
Payment of Dividends		 -91 -101 -109 -122 -87 -152 -164 -177 -186 -201 -216
Other Financing Activities, net		 132 84 96 92 81 34 96 87 65 39 8.17
Cash Interest Paid		 0.63 0.55 0.58 1.15 2.01 7.35 5.39 19 17 19 35
Cash Income Taxes Paid		 59 51 50 68 56 76 45 146 80 156 188

Quarterly Cash Flow Statements for Amdocs

No quarterly cash flow statements for Amdocs are available.

Annual Balance Sheets for Amdocs

This table presents Amdocs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Total Assets		 5,185 5,325 5,331 5,279 5,348 5,293 6,342 6,512 6,390 6,426 6,386
Total Current Assets		 2,424 2,378 2,100 2,048 1,721 1,676 2,075 2,067 2,003 1,912 1,771
Cash & Equivalents		 1,103 1,036 769 650 419 472 983 709 573 520 346
Short-Term Investments		 321 318 327 330 100 0.00 0.75 257 245 222 168
Accounts Receivable		 716 715 819 865 972 988 861 867 947 944 1,028
Prepaid Expenses		 135 159 186 204 230 216 230 235 238 225 228
Plant, Property, & Equipment, net		 289 309 332 356 497 525 608 699 794 791 756
Total Noncurrent Assets		 2,472 2,637 2,899 2,875 3,131 3,092 3,659 3,746 3,593 3,723 3,859
Goodwill		 1,925 2,049 2,212 2,221 2,445 2,463 2,579 2,623 2,663 2,749 2,845
Intangible Assets		 181 253 282 177 265 205 296 259 178 182 161
Other Noncurrent Operating Assets		 366 336 406 477 420 424 784 864 752 793 854
Total Liabilities & Shareholders' Equity		 5,185 5,325 5,331 5,279 5,348 5,293 6,342 6,512 6,390 6,426 6,386
Total Liabilities		 1,789 1,918 1,878 1,705 1,856 1,750 2,676 2,877 2,830 2,859 2,887
Total Current Liabilities		 1,201 1,364 1,366 1,173 1,295 1,208 1,216 1,304 1,253 1,353 1,471
Accounts Payable		 143 112 137 126 195 177 110 121 134 293 306
Accrued Expenses		 422 609 612 668 707 648 594 612 613 635 779
Current Deferred Revenue		 157 198 173 113 132 118 127 237 254 171 115
Current Employee Benefit Liabilities		 221 224 244 265 261 266 227 274 209 215 231
Other Current Liabilities		 - - - - - 0.00 59 59 43 40 40
Total Noncurrent Liabilities		 589 554 512 532 561 542 1,460 1,573 1,577 1,505 1,416
Long-Term Debt		 - - - - - 0.00 644 645 645 646 646
Noncurrent Deferred & Payable Income Tax Liabilities		 311 306 227 219 225 208 258 305 312 253 198
Other Noncurrent Operating Liabilities		 278 248 285 313 336 335 558 624 620 607 572
Total Equity & Noncontrolling Interests		 3,396 3,407 3,454 3,574 3,492 3,542 3,665 3,635 3,560 3,567 3,499
Total Preferred & Common Equity		 3,396 3,407 3,454 3,574 3,449 3,500 3,623 3,593 3,518 3,524 3,457
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 3,396 3,407 3,454 3,574 3,449 3,500 3,623 3,593 3,518 3,524 3,457
Common Stock		 3,059 3,187 3,327 3,463 3,592 3,672 3,812 3,956 4,110 4,249 4,418
Retained Earnings		 3,504 3,848 4,145 4,457 4,674 5,013 5,342 5,851 6,212 6,550 6,828
Treasury Stock		 -3,157 -3,611 -4,025 -4,365 -4,784 -5,182 -5,543 -6,223 -6,732 -7,221 -7,784
Accumulated Other Comprehensive Income / (Loss)		 -9.97 -17 6.10 19 -33 -2.55 12 9.34 -72 -53 -4.41
Noncontrolling Interest		 - - - 0.00 43 43 43 43 43 43 42

Quarterly Balance Sheets for Amdocs

No quarterly balance sheets for Amdocs are available.

Annual Metrics And Ratios for Amdocs

This table displays calculated financial ratios and metrics derived from Amdocs' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 6.51% 2.24% 2.05% 4.01% 2.78% 2.81% 2.02% 2.87% 6.72% 6.79% 2.40%
EBITDA Growth		 -47.10% 4.91% 0.61% 4.73% -12.13% 20.97% 1.06% 30.93% -14.67% -4.68% -5.75%
EBIT Growth		 -48.54% 4.10% -6.36% 6.16% -16.50% 32.59% 2.72% 39.60% -20.37% -1.86% -7.12%
NOPAT Growth		 2.32% 4.91% -9.00% 7.98% -18.27% 33.58% 5.53% -0.29% 11.32% -0.96% -5.41%
Net Income Growth		 2.35% 5.70% -8.26% 6.72% -18.87% 35.29% 3.84% 38.27% -20.17% -1.19% -8.59%
EPS Growth		 3.56% 8.78% -4.91% 9.23% -16.55% 40.49% 6.92% 43.40% -16.54% 1.13% -5.35%
Operating Cash Flow Growth		 5.77% 8.93% -19.72% 2.56% -12.40% 17.79% 0.27% 40.67% -18.26% 8.71% -11.94%
Free Cash Flow Firm Growth		 2.62% -9.51% -65.54% 228.41% -104.53% 2,195.26% -60.00% 302.88% -20.59% -3.02% -22.83%
Invested Capital Growth		 1.53% 4.19% 12.54% 1.43% 14.58% 3.30% 11.54% -3.24% 2.21% 2.44% 4.64%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 35.27% 35.52% 35.24% 35.16% 34.71% 35.08% 33.90% 34.46% 35.38% 35.35% 35.07%
EBITDA Margin		 18.48% 18.96% 18.69% 18.82% 16.09% 18.93% 18.75% 23.87% 19.09% 17.04% 15.68%
Operating Margin		 13.91% 14.16% 12.99% 13.38% 10.78% 13.94% 14.27% 13.96% 14.53% 13.38% 12.56%
EBIT Margin		 13.91% 14.16% 12.99% 13.26% 10.78% 13.90% 13.99% 18.99% 14.17% 13.02% 11.81%
Profit (Net Income) Margin		 11.85% 12.25% 11.01% 11.30% 8.92% 11.73% 11.94% 16.05% 12.01% 11.11% 9.92%
Tax Burden Percent		 86.23% 86.90% 84.45% 85.17% 84.07% 84.43% 85.35% 84.54% 84.75% 85.32% 83.97%
Interest Burden Percent		 98.77% 99.51% 100.32% 100.00% 98.42% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 13.77% 13.10% 15.55% 14.83% 15.93% 15.57% 14.65% 15.46% 15.25% 14.68% 16.03%
Return on Invested Capital (ROIC)		 19.74% 20.13% 16.89% 17.10% 12.94% 15.92% 15.63% 15.02% 16.81% 16.27% 14.87%
ROIC Less NNEP Spread (ROIC-NNEP)		 20.19% 20.32% 16.76% 17.50% 13.69% 16.23% 18.37% -49.97% 22.44% 27.43% -164.59%
Return on Net Nonoperating Assets (RNNOA)		 -7.09% -7.02% -4.96% -4.67% -2.90% -2.29% -1.81% 3.84% -1.54% -1.04% -0.82%
Return on Equity (ROE)		 12.66% 13.12% 11.93% 12.43% 10.03% 13.63% 13.81% 18.86% 15.27% 15.24% 14.05%
Cash Return on Invested Capital (CROIC)		 18.22% 16.03% 5.09% 15.68% -0.66% 12.67% 4.72% 18.32% 14.63% 13.86% 10.33%
Operating Return on Assets (OROA)		 9.80% 9.82% 9.07% 9.67% 8.06% 10.67% 10.03% 12.67% 10.05% 9.93% 9.23%
Return on Assets (ROA)		 8.35% 8.49% 7.68% 8.23% 6.67% 9.01% 8.56% 10.71% 8.52% 8.47% 7.75%
Return on Common Equity (ROCE)		 12.66% 13.12% 11.93% 12.43% 9.97% 13.47% 13.65% 18.64% 15.09% 15.05% 13.88%
Return on Equity Simple (ROE_SIMPLE)		 12.43% 13.10% 11.85% 12.22% 10.28% 13.70% 13.74% 19.16% 15.62% 15.41% 14.36%
Net Operating Profit after Tax (NOPAT)		 427 448 408 441 360 481 508 506 563 558 528
NOPAT Margin		 11.99% 12.31% 10.97% 11.39% 9.06% 11.77% 12.18% 11.80% 12.31% 11.42% 10.55%
Net Nonoperating Expense Percent (NNEP)		 -0.45% -0.19% 0.13% -0.40% -0.76% -0.32% -2.74% 64.99% -5.62% -11.15% 179.45%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 13.40% 13.25% 12.73%
Cost of Revenue to Revenue		 64.73% 64.48% 64.76% 64.85% 65.29% 64.92% 66.10% 65.54% 64.62% 64.65% 64.93%
SG&A Expenses to Revenue		 12.49% 12.08% 12.50% 12.23% 12.10% 12.05% 11.00% 11.36% 11.55% 11.68% 11.45%
R&D to Revenue		 7.24% 7.00% 6.79% 6.70% 6.96% 6.70% 6.77% 7.30% 7.75% 7.67% 7.21%
Operating Expenses to Revenue		 21.36% 21.36% 22.24% 21.78% 23.93% 21.14% 19.64% 20.50% 20.85% 21.97% 22.51%
Earnings before Interest and Taxes (EBIT)		 496 516 483 513 428 568 583 814 648 636 591
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 658 691 695 728 640 774 782 1,024 874 833 785
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.85 2.27 2.22 2.36 2.50 2.44 2.01 2.66 2.71 2.83 2.97
Price to Tangible Book Value (P/TBV)		 4.88 6.99 8.00 7.17 11.66 10.26 9.73 13.42 14.08 16.84 22.74
Price to Revenue (P/Rev)		 1.76 2.12 2.07 2.18 2.17 2.09 1.75 2.22 2.08 2.04 2.05
Price to Earnings (P/E)		 14.90 17.32 18.77 19.30 24.30 17.80 14.62 13.86 17.34 18.47 20.81
Dividend Yield		 1.51% 1.35% 1.49% 1.49% 1.63% 1.82% 2.35% 1.94% 2.03% 2.06% 2.14%
Earnings Yield		 6.71% 5.77% 5.33% 5.18% 4.12% 5.62% 6.84% 7.21% 5.77% 5.41% 4.80%
Enterprise Value to Invested Capital (EV/IC)		 2.33 2.90 2.65 2.87 2.74 2.64 2.07 2.80 2.77 2.86 2.88
Enterprise Value to Revenue (EV/Rev)		 1.42 1.81 1.83 1.93 2.05 1.98 1.70 2.16 2.05 2.03 2.09
Enterprise Value to EBITDA (EV/EBITDA)		 7.71 9.55 9.77 10.24 12.72 10.47 9.06 9.05 10.76 11.93 13.30
Enterprise Value to EBIT (EV/EBIT)		 10.24 12.78 14.05 14.52 18.99 14.27 12.14 11.38 14.49 15.61 17.66
Enterprise Value to NOPAT (EV/NOPAT)		 11.87 14.71 16.63 16.91 22.59 16.85 13.95 18.30 16.68 17.80 19.78
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.15 8.53 10.94 11.71 14.60 12.35 10.76 10.01 12.42 12.08 14.41
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.86 18.47 55.17 18.44 0.00 21.16 46.22 15.01 19.17 20.90 28.46
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.06 0.06 0.06 0.00 0.00 0.00 0.20 0.18 0.18 0.18 0.18
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.18 0.18 0.18 0.18 0.18
Financial Leverage		 -0.35 -0.35 -0.30 -0.27 -0.21 -0.14 -0.10 -0.08 -0.07 -0.04 0.01
Leverage Ratio		 1.52 1.55 1.55 1.51 1.50 1.51 1.61 1.76 1.79 1.80 1.81
Compound Leverage Factor		 1.50 1.54 1.56 1.51 1.48 1.51 1.61 1.76 1.79 1.80 1.81
Debt to Total Capital		 5.82% 6.07% 5.47% 0.00% 0.00% 0.00% 16.87% 15.06% 15.34% 15.33% 15.59%
Short-Term Debt to Total Capital		 5.82% 6.07% 5.47% 0.00% 0.00% 0.00% 2.27% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 14.61% 15.06% 15.34% 15.33% 15.59%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 1.24% 1.20% 0.96% 0.99% 1.01% 1.02% 1.02%
Common Equity to Total Capital		 94.18% 93.93% 94.53% 100.00% 98.76% 98.80% 82.16% 83.95% 83.65% 83.65% 83.39%
Debt to EBITDA		 0.32 0.32 0.29 0.00 0.00 0.00 0.95 0.63 0.74 0.78 0.82
Net Debt to EBITDA		 -1.84 -1.64 -1.29 0.00 0.00 0.00 -0.31 -0.31 -0.20 -0.12 0.17
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.82 0.63 0.74 0.78 0.82
Debt to NOPAT		 0.49 0.49 0.49 0.00 0.00 0.00 1.47 1.27 1.15 1.16 1.22
Net Debt to NOPAT		 -2.84 -2.53 -2.20 0.00 0.00 0.00 -0.47 -0.63 -0.31 -0.17 0.25
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 1.27 1.27 1.15 1.16 1.22
Altman Z-Score		 4.34 4.66 4.70 5.40 5.11 5.48 3.93 4.46 4.57 4.72 4.78
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.61% 1.22% 1.18% 1.16% 1.18% 1.20% 1.21%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.02 1.74 1.54 1.75 1.33 1.39 1.71 1.59 1.60 1.41 1.20
Quick Ratio		 1.78 1.52 1.40 1.57 1.15 1.21 1.52 1.41 1.41 1.25 1.05
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 394 357 123 404 -18 383 153 617 490 475 367
Operating Cash Flow to CapEx		 635.71% 641.16% 476.79% 476.87% 241.08% 512.45% 320.25% 439.94% 333.04% 661.48% 686.69%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.70 0.69 0.70 0.73 0.75 0.77 0.72 0.67 0.71 0.76 0.78
Accounts Receivable Turnover		 5.11 5.09 4.85 4.59 4.33 4.17 4.51 4.96 5.05 5.17 5.07
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 12.63 12.18 11.60 11.25 9.33 8.00 7.36 6.56 6.13 6.17 6.47
Accounts Payable Turnover		 16.76 18.46 19.37 19.06 16.16 14.29 19.23 24.30 23.14 14.77 10.85
Days Sales Outstanding (DSO)		 71.39 71.66 75.26 79.45 84.32 87.50 80.94 73.53 72.32 70.62 71.94
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 21.78 19.78 18.84 19.15 22.58 25.54 18.98 15.02 15.77 24.70 33.66
Cash Conversion Cycle (CCC)		 49.61 51.88 56.41 60.31 61.74 61.96 61.95 58.51 56.55 45.92 38.28
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,181 2,273 2,558 2,594 2,973 3,071 3,425 3,314 3,387 3,470 3,631
Invested Capital Turnover		 1.65 1.64 1.54 1.50 1.43 1.35 1.28 1.27 1.37 1.43 1.41
Increase / (Decrease) in Invested Capital		 33 91 285 37 378 98 354 -111 73 83 161
Enterprise Value (EV)		 5,073 6,593 6,786 7,449 8,135 8,104 7,080 9,263 9,396 9,935 10,440
Market Capitalization		 6,288 7,727 7,682 8,429 8,611 8,533 7,278 9,541 9,526 9,989 10,266
Book Value per Share		 $21.22 $21.74 $22.85 $24.29 $23.89 $24.97 $26.88 $27.31 $28.17 $29.16 $29.46
Tangible Book Value per Share		 $8.06 $7.05 $6.35 $7.99 $5.12 $5.94 $5.55 $5.41 $5.42 $4.91 $3.85
Total Capital		 3,606 3,627 3,654 3,574 3,492 3,542 4,409 4,280 4,205 4,213 4,145
Total Debt		 210 220 200 0.00 0.00 0.00 744 645 645 646 646
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 644 645 645 646 646
Net Debt		 -1,214 -1,134 -896 -980 -519 -472 -240 -321 -173 -97 132
Capital Expenditures (CapEx)		 112 121 130 133 231 128 206 210 227 124 105
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 8.76 -119 -161 -104 -93 -3.99 -26 -202 -68 -184 -214
Debt-free Net Working Capital (DFNWC)		 1,433 1,235 934 876 426 468 958 764 750 558 300
Net Working Capital (NWC)		 1,223 1,015 734 876 426 468 858 764 750 558 300
Net Nonoperating Expense (NNE)		 5.26 2.21 -1.31 3.77 5.69 1.57 9.76 -182 14 15 32
Net Nonoperating Obligations (NNO)		 -1,214 -1,134 -896 -980 -519 -472 -240 -321 -173 -97 132
Total Depreciation and Amortization (D&A)		 163 175 212 215 211 206 199 209 225 196 194
Debt-free, Cash-free Net Working Capital to Revenue		 0.25% -3.28% -4.34% -2.69% -2.35% -0.10% -0.61% -4.71% -1.48% -3.77% -4.28%
Debt-free Net Working Capital to Revenue		 40.22% 33.89% 25.13% 22.64% 10.71% 11.44% 22.99% 17.81% 16.40% 11.42% 6.00%
Net Working Capital to Revenue		 34.33% 27.85% 19.75% 22.64% 10.71% 11.44% 20.59% 17.81% 16.40% 11.42% 6.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.65 $2.89 $2.74 $2.99 $2.49 $0.00 $3.73 $5.36 $4.47 $4.52 $4.27
Adjusted Weighted Average Basic Shares Outstanding		 159.01M 151.15M 147.13M 144.39M 140.18M 0.00 131.54M 124.87M 120.84M 117.35M 112.89M
Adjusted Diluted Earnings per Share		 $2.62 $2.85 $2.71 $2.96 $2.47 $0.00 $3.71 $5.32 $4.44 $4.49 $4.25
Adjusted Weighted Average Diluted Shares Outstanding		 161.37M 151.15M 147.13M 144.39M 140.18M 0.00 131.54M 124.87M 120.84M 117.35M 112.89M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 156.70M 151.15M 147.13M 144.39M 140.18M 0.00 131.54M 124.87M 120.84M 117.35M 112.89M
Normalized Net Operating Profit after Tax (NOPAT)		 427 460 408 441 432 481 508 506 563 618 638
Normalized NOPAT Margin		 11.99% 12.62% 10.97% 11.39% 10.86% 11.77% 12.18% 11.80% 12.31% 12.65% 12.75%
Pre Tax Income Margin		 13.74% 14.09% 13.04% 13.26% 10.61% 13.90% 13.99% 18.99% 14.17% 13.02% 11.81%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 21.54% 22.59% 26.70% 27.82% 24.63% 31.79% 32.95% 25.78% 33.86% 37.03% 43.53%
Augmented Payout Ratio		 109.67% 124.35% 127.70% 105.79% 142.92% 114.81% 105.45% 124.56% 126.40% 127.19% 156.99%

Quarterly Metrics And Ratios for Amdocs

No quarterly metrics and ratios for Amdocs are available.

Frequently Asked Questions About Amdocs' Financials

When does Amdocs' fiscal year end?

According to the most recent income statement we have on file, Amdocs' financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Amdocs' net income changed over the last 10 years?

Amdocs' net income appears to be on an upward trend, with a most recent value of $496.32 million in 2024, rising from $422.12 million in 2014. The previous period was $542.96 million in 2023. See Amdocs' forecast for analyst expectations on what’s next for the company.

What is Amdocs' operating income?
Amdocs' total operating income in 2024 was $628.61 million, based on the following breakdown:
  • Total Gross Profit: $1.76 billion
  • Total Operating Expenses: $1.13 billion
How has Amdocs' revenue changed over the last 10 years?

Over the last 10 years, Amdocs' total revenue changed from $3.56 billion in 2014 to $5.00 billion in 2024, a change of 40.4%.

How much debt does Amdocs have?

Amdocs' total liabilities were at $2.89 billion at the end of 2024, a 1.0% increase from 2023, and a 61.3% increase since 2014.

How much cash does Amdocs have?

In the past 10 years, Amdocs' cash and equivalents has ranged from $346.09 million in 2024 to $1.10 billion in 2014, and is currently $346.09 million as of their latest financial filing in 2024.

How has Amdocs' book value per share changed over the last 10 years?

Over the last 10 years, Amdocs' book value per share changed from 21.22 in 2014 to 29.46 in 2024, a change of 38.9%.


Related Companies

This page (NASDAQ:DOX) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...
American Alternative | Sponsored
The IRS Loophole That Lets You Own Gold Tax-Free
What if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...
Advantage Gold | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored